Disclaimer: This article is for informational purposes only and does not constitute medical advice.
When you receive a cancer diagnosis, the pathology report becomes the single most important document in your medical journey. It determines your cancer type, stage, grade, and the molecular markers that guide every treatment decision. But what happens when that report is wrong?
Research shows that pathology errors are more common than most patients realise. A study at Moffitt Cancer Center found an overall discordance rate of 14.2% in surgical pathology cases, with 2.2% classified as major discrepancies that could directly affect patient care.
A cancer pathology second opinion is not a luxury — it is a proven patient safety measure that could change your diagnosis, your treatment, and your outcome. In this guide, we explore why pathology review matters, which cancers carry the highest misdiagnosis risk, how to request a second opinion, and what the research says about this often-overlooked step in cancer care.
What Is a Cancer Pathology Report and Why Does It Matter?
A pathology report is the definitive document that confirms whether tissue removed during a biopsy or surgery contains cancer. It goes beyond a simple yes-or-no answer, including the cancer type and subtype, tumour grade, stage, surgical margin status, and molecular and genetic markers that determine which targeted therapies may be effective.
The pathologist — often called the “doctor’s doctor” — is a physician who specialises in examining tissue samples. While you may never meet your pathologist face to face, their interpretation shapes every subsequent treatment decision. If the pathologist overestimates the cancer grade, you might undergo aggressive chemotherapy you don’t need. If they miss certain molecular markers, you could lose access to a targeted therapy that would significantly improve your prognosis.
Pathology is not always straightforward. Many diagnoses require subjective interpretation, and according to research published in Anticancer Research, even experienced pathologists can disagree on tumour classification — particularly in complex cases involving rare cancers or borderline lesions. This inherent subjectivity is precisely why a second opinion serves as a critical safety net.
Understanding the warning signs of a potential misdiagnosis can help you determine whether seeking a pathology review is the right step for your situation.
How Often Do Cancer Pathology Errors Occur? The Research
While most pathology reports are accurate, a significant minority contain errors ranging from minor discrepancies to major diagnostic changes that alter treatment plans entirely.
A retrospective study at Moffitt Cancer Center reviewed 9,289 cases submitted for second-opinion review. The overall discordance rate was 14.2%, with 2.2% of cases showing major discrepancies that would affect patient management. Among major diagnostic disagreements, 75.3% involved outright diagnosis changes, while 10.4% involved changes to tumour grading.
Breast cancer pathology has received particular scrutiny. Research has shown that up to 43% of women diagnosed with breast cancer who sought a second opinion at a National Cancer Institute-designated cancer centre received a change in their diagnosis or treatment recommendations.
For lymphoma, studies found that second opinions changed the staging for approximately 36% of patients with diffuse large B-cell lymphoma — a change that directly affects treatment choice and can mean the difference between cure and recurrence.
A broader review in Cancer Medicine from Memorial Sloan Kettering found that more than one-third of patients experienced clinically meaningful treatment changes following expert review. Meanwhile, BMJ Quality & Safety data shows approximately 795,000 Americans are harmed or killed annually by diagnostic errors, with the National Coalition for Cancer Survivorship estimating that more than 1 in 10 cancer patients receive an initial misdiagnosis.
Which Cancers Are Most Commonly Misdiagnosed in Pathology?
While pathology errors can occur with any type of cancer, certain cancers are disproportionately affected by diagnostic discrepancies. Understanding which types carry the highest risk can help you make informed decisions about seeking a second opinion.
Lymphoma
Lymphoma is one of the most challenging cancers to diagnose accurately. The WHO classification includes dozens of distinct subtypes with overlapping microscopic features. Misclassification between subtypes — or between lymphoma and reactive lymphoid conditions — leads to dramatically different treatment approaches, with some analyses finding discordance rates exceeding 15%.
Sarcoma
Soft tissue sarcomas are rare cancers with more than 70 subtypes. Their rarity means many community pathologists may encounter only a handful of cases in their career. Expert sarcoma pathologists at specialist centres frequently reclassify tumours initially diagnosed at community hospitals.
Melanoma
The distinction between melanoma and benign melanocytic lesions is one of the most contested areas in dermatopathology. A JAMA Network Open study found that misclassification was highest among pathologists without subspecialty training. Overdiagnosis leads to unnecessary surgery, while underdiagnosis can allow a deadly cancer to progress.
Breast Cancer
Distinguishing between ductal carcinoma in situ (DCIS), atypical ductal hyperplasia (ADH), and invasive breast cancer requires considerable expertise. Misclassification between ADH and DCIS is particularly common — DCIS typically requires surgery and possibly radiation, while ADH usually requires only monitoring.
Brain Tumours (Neuropathology)
The Moffitt study found neuropathology had the highest major discrepancy rate at 10.9% — nearly five times the overall average. The distinction between high-grade and low-grade gliomas fundamentally changes whether a patient receives aggressive treatment or a watch-and-wait approach.
Gynaecological Cancers
Gynaecological cytopathology showed major discrepancy rates of 12.5% in the Moffitt study. Borderline ovarian tumours are a well-known source of disagreement among pathologists.
If you have been diagnosed with any of these cancers, seeking a pathology second opinion is particularly important. For more information on cancers that are frequently misdiagnosed, read our detailed guide on the 7 most commonly misdiagnosed cancers.
What Happens During a Pathology Second Opinion?
Understanding the process of obtaining a pathology second opinion can help demystify what may feel like an intimidating step. Here is what typically happens from start to finish.
Step 1: Request Your Pathology Materials
The first step is to contact the pathology department at the hospital or laboratory where your original biopsy or surgery was performed. You will need to request that your pathology slides (the actual glass slides containing thin slices of your tissue), tissue blocks (the preserved tissue samples embedded in paraffin wax), and the original pathology report be sent to the reviewing institution. Under patient rights laws in the United States, United Kingdom, and Australia, you have the legal right to access your medical records, including pathology materials.
In the US, the Health Insurance Portability and Accountability Act (HIPAA) guarantees your right to obtain copies of your medical records. In the UK, while there is no absolute legal right to a second opinion, NHS guidelines state that doctors must respect your right to seek one, and your GP or specialist can arrange a referral. In Australia, Cancer Australia actively encourages patients to seek second opinions and provides resources to facilitate the process.
Step 2: Choose a Reviewing Pathologist or Institution
Ideally, your second opinion should come from a pathologist with subspecialty expertise in your particular type of cancer. Academic medical centres, NCI-designated cancer centres (in the US), and NHS specialist cancer centres (in the UK) typically have pathologists with focused expertise. Memorial Sloan Kettering Cancer Center, for example, processes approximately 5,000 to 6,000 second opinion pathology reviews annually alongside its own caseload of over 14,000 cases per year.
Step 3: Expert Review of Your Slides
The reviewing pathologist examines your original tissue slides under the microscope, often alongside additional immunohistochemical stains or molecular tests that may not have been performed initially. They review the original pathology report independently and compare their findings. This process typically takes a few days to a week, though complex cases may take longer.
As Dr. Edi Brogi of Memorial Sloan Kettering has noted, prioritising diagnostic accuracy over speed is essential: “A difficult case may take longer, but that probably really needs a second opinion.”
Step 4: Receive the Second Opinion Report
The reviewing pathologist prepares a detailed report of their findings, which is sent to your treating physician. The report may confirm the original diagnosis, suggest modifications (such as a change in tumour grade or subtype), or in some cases, present a fundamentally different diagnosis. Your oncologist will then discuss the findings with you and, if necessary, adjust your treatment plan accordingly.
Step 5: Reconcile Any Discrepancies
If the second opinion disagrees with the original diagnosis, your treating physician may seek a third opinion or convene a tumour board — a multidisciplinary team of specialists who collectively review complex cases. This collaborative approach ensures that the final diagnosis reflects the best available evidence and expert consensus.
How a Pathology Second Opinion Can Change Your Treatment
The implications of a changed pathology diagnosis can be profound and far-reaching. Here are real-world scenarios that illustrate how a second opinion can alter the course of treatment.
Avoiding Unnecessary Treatment
Consider a patient originally diagnosed with ductal carcinoma in situ (DCIS) of the breast. Based on this diagnosis, surgery followed by radiation therapy was recommended. A pathology second opinion reclassified the lesion as atypical ductal hyperplasia (ADH) — a precancerous condition that typically requires only close monitoring rather than aggressive treatment. This single reclassification spared the patient surgery, radiation, and the associated physical and emotional toll.
Ensuring Adequate Treatment
Conversely, a patient diagnosed with a low-grade lymphoma might be placed on a watch-and-wait protocol. A second pathology review that reclassifies the tumour as a more aggressive subtype could prompt earlier and more intensive treatment — potentially catching the cancer at a stage when it is still highly curable.
Unlocking Targeted Therapies
Modern cancer treatment increasingly relies on molecular and genetic markers to guide therapy selection. A pathology second opinion that includes additional molecular testing may identify markers such as HER2 positivity in breast cancer, specific mutations in lung cancer (like EGFR or ALK), or microsatellite instability status in colorectal cancer. These findings can open the door to targeted therapies and immunotherapies that significantly improve survival rates.
Changing Surgical Plans
The extent of surgery recommended for cancer often depends on the pathology diagnosis. A second opinion that changes the tumour type, grade, or margin status may change whether a patient needs a lumpectomy versus a mastectomy, limb-sparing surgery versus amputation for sarcoma, or the extent of lymph node dissection required. Research suggests that a 4-week delay in cancer surgery can raise mortality risk by 6-8%, making timely and accurate diagnosis all the more critical.
Financial Impact
Beyond the health implications, pathology errors carry significant financial consequences. The Everylife Foundation estimates that delayed diagnosis of rare diseases costs an average of $517,000 per person in unnecessary treatments, additional testing, and prolonged care. A second opinion that corrects a misdiagnosis early can save patients and health systems tens of thousands of dollars in averted unnecessary treatments.
The Rise of Digital Pathology and Remote Second Opinions
Technology is transforming how pathology second opinions are obtained, making expert review more accessible than ever before — regardless of where a patient lives.
What Is Digital Pathology?
Digital pathology involves scanning glass tissue slides at high resolution to create digital images that can be shared electronically. Expert pathologists anywhere in the world can review these images without physically shipping glass slides.
Benefits for Second Opinions
Digital pathology has dramatically reduced turnaround times. What once required mailing glass slides can now be accomplished in hours. A 2025 study in Current Urology Reports confirmed that digital pathology enables effective global second opinions with accuracy comparable to traditional glass slide review. For patients in rural areas — regional Australia, rural America, or smaller UK towns — this technology is transformative, providing access to expert review that was previously available only at major academic centres.
AI-Assisted Pathology
AI algorithms can help pathologists identify subtle patterns, flag areas of concern, and provide preliminary tumour classifications. While not replacing human pathologists, AI serves as a powerful complementary tool for improving accuracy and consistency. For more on this topic, see our article on how AI is changing medical second opinions in 2026.
Telepathology Services
Several major cancer centres now offer telepathology programmes that allow community pathologists to share cases electronically with subspecialist experts. The COVID-19 pandemic accelerated adoption of these workflows, which have continued to expand.
When Should You Get a Cancer Pathology Second Opinion?
While a second pathology opinion is valuable in many situations, certain circumstances make it particularly important. Consider seeking a second opinion if any of the following apply to your situation.
You Have a Rare or Complex Cancer
Rare cancers — including sarcomas, rare lymphoma subtypes, neuroendocrine tumours, and uncommon brain tumours — are more frequently misdiagnosed. Having your diagnosis reviewed by a subspecialist at a high-volume cancer centre is strongly recommended.
Your Diagnosis Was Made at a Community Hospital
Community hospitals provide excellent care, but their pathology departments may lack the subspecialty expertise and molecular testing capabilities available at academic centres. A second opinion provides reassurance and may identify opportunities for additional testing.
You Are Facing Major Surgery or Aggressive Treatment
Dr. Edi Brogi of Memorial Sloan Kettering advises that “a second opinion should be obtained before any definitive surgery, like a mastectomy, or a treatment with substantial side effects, such as radiation therapy or chemotherapy.”
Your Symptoms Don’t Match the Diagnosis
If your clinical presentation does not align with what would be expected based on your diagnosis, this discrepancy warrants further investigation. Your body may be telling you something the pathology report missed.
The Pathology Report Is Ambiguous
Reports that use hedging language — “consistent with,” “suggestive of,” “cannot exclude” — indicate diagnostic uncertainty. If your doctor describes the case as “borderline” or “atypical,” a second opinion is especially important.
Your Treatment Is Not Working as Expected
If you are not responding to treatment as expected, the underlying diagnosis should be re-evaluated. Treatment resistance can sometimes be explained by a misclassified tumour type or missed molecular markers.
How Much Does a Cancer Pathology Second Opinion Cost?
One of the most common concerns patients have about seeking a second opinion is the cost. The good news is that pathology second opinions are more affordable and more widely covered than many patients expect.
Insurance Coverage
In the United States, most major health insurance plans — including Medicare, Blue Cross Blue Shield, Aetna, and UnitedHealthcare — cover pathology second opinions for cancer diagnoses. Medicare explicitly covers second surgical opinions and related diagnostic tests.
In the United Kingdom, second opinions obtained through NHS referral are free. Your GP or specialist can refer you to another NHS consultant. Private second opinions typically range from £200 to £500.
In Australia, second opinions through the public health system are covered by Medicare. Private consultations may incur out-of-pocket costs depending on your health insurance coverage.
Out-of-Pocket Costs
For patients paying out of pocket in the US, pathology second opinions typically cost $200 to $500 depending on complexity. Some centres offer financial assistance programmes. Considering that incorrect treatment can cost tens of thousands of dollars, a second opinion represents a modest investment with potentially enormous returns.
Institutional Programmes
Major cancer centres including Dana-Farber, MD Anderson, and Memorial Sloan Kettering offer formal second opinion programmes with streamlined processes. Some can be initiated online, with slides shipped directly to the reviewing institution.
Your Step-by-Step Action Plan for Getting a Cancer Pathology Second Opinion
If you have decided to seek a pathology second opinion, follow this practical roadmap to navigate the process efficiently.
1. Talk to your oncologist. Let your treating physician know you would like a second opinion. Most oncologists welcome this step and can recommend appropriate reviewing institutions. Remember, seeking a second opinion is your right — a good doctor will support your decision, not discourage it.
2. Request your pathology materials. Contact the pathology department where your biopsy or surgery was performed. Request that your glass slides, tissue blocks, and original pathology report be prepared for transfer. Some institutions have dedicated release-of-records departments that handle these requests. For more guidance on obtaining your records, read our article on how to request medical records for a second opinion.
3. Choose your reviewing institution. Select a cancer centre with subspecialty expertise in your type of cancer. NCI-designated cancer centres in the US, NHS specialist cancer centres in the UK, and major academic hospitals in Australia are excellent choices. If digital pathology is available, you may be able to have your slides scanned and reviewed remotely.
4. Verify insurance coverage. Contact your insurance provider to confirm coverage for a pathology second opinion. Ask about any pre-authorisation requirements. If paying out of pocket, inquire about the cost directly with the reviewing institution.
5. Coordinate the transfer. Your pathology materials can be shipped by courier (most institutions use tracked, insured shipping) or, increasingly, transmitted digitally. Ensure you receive a tracking number and confirm receipt with the reviewing institution.
6. Follow up on the timeline. Most pathology second opinions are completed within one to two weeks. Contact the reviewing institution if you have not received results within the expected timeframe.
7. Discuss the results with your oncologist. Once the second opinion report is available, review it with your treating physician. Discuss any discrepancies and how they may affect your treatment plan. If the opinions conflict, ask about the possibility of a tumour board review.
Frequently Asked Questions About Cancer Pathology Second Opinions
Will my doctor be offended if I ask for a pathology second opinion?
No. Most oncologists and pathologists actively support patients seeking second opinions, and many cancer centres require an internal second pathology review as standard protocol before finalising a diagnosis. The American Society of Clinical Oncology and major cancer organisations worldwide encourage patients to seek second opinions. A doctor who discourages you from seeking a second opinion may not be acting in your best interest.
How long does a pathology second opinion take?
Most pathology second opinions are completed within a few days to two weeks, depending on the complexity of the case and the reviewing institution’s workload. Digital pathology has significantly reduced turnaround times. As Dr. Edi Brogi of Memorial Sloan Kettering notes, while speed is important, “a difficult case may take longer, but that probably really needs a second opinion.” For most cancers, a one-to-two-week delay for a second opinion does not meaningfully affect outcomes, while an incorrect diagnosis can have devastating consequences.
Can I get a pathology second opinion if I live in a rural area or outside a major city?
Yes. Digital pathology and telepathology services have made second opinions accessible regardless of geographic location. Many major cancer centres accept shipped pathology slides and some now offer fully digital review services where your glass slides are scanned at your local hospital and transmitted electronically. Patients in regional Australia, rural America, and smaller UK towns can all access expert pathology review.
What should I do if the second opinion disagrees with the first?
If the second opinion differs from the original diagnosis, your treating physician should review both reports and discuss the implications with you. In many cases, a multidisciplinary tumour board — comprising oncologists, surgeons, radiologists, and pathologists — will review the case collectively to reach a consensus diagnosis. A third pathology opinion may also be sought. The goal is to ensure the most accurate diagnosis possible before proceeding with treatment.
Does a pathology second opinion delay my cancer treatment?
While a pathology second opinion does add a short period to the diagnostic process — typically one to two weeks — this delay is generally considered safe for most cancer types and is far outweighed by the risks of proceeding with treatment based on an incorrect diagnosis. Research shows that the most significant treatment delays occur due to diagnostic errors themselves, not due to the time spent confirming the diagnosis. If your cancer is particularly time-sensitive, your oncologist can often arrange an expedited review.
The Bottom Line: A Pathology Second Opinion Is a Patient Safety Essential
Cancer diagnosis is one of the most consequential determinations in medicine, and pathology is its foundation. With research showing that 1 in 7 cancer pathology cases contains some form of discrepancy, the case for seeking a second opinion is compelling.
A second opinion is not a sign of distrust — it is a proven safety practice that major cancer centres recommend and routinely perform. It can confirm your diagnosis and give you confidence, or catch an error that changes your treatment and potentially saves your life.
Whether you are newly diagnosed, facing a rare cancer, or preparing for major surgery, having your pathology reviewed by a subspecialist is one of the most important steps you can take. The process is straightforward, increasingly accessible through digital technology, and in most cases covered by insurance. Your diagnosis matters — and you deserve to know it is right.
Have you been recently diagnosed with cancer? Explore our guides on when to get a second opinion before surgery and the best telemedicine platforms for medical second opinions to learn more about your options.